HighTower Advisors
MDT icon

HighTower Advisors’s Medtronic MDT Stock Holding History

HighTower Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$116K – 3925
2024
Q4 		$116K Buy
+50,000
New +$4.33M ﹤0.01% 3346
2022
Q1 		– Sell
-11
Closed -$37K – 3565
2021
Q4 		$37K Buy
+11
New +$1.27K ﹤0.01% 3052

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's MDT Position: Q1 2026 in Review

HighTower Advisors reduced its Medtronic (MDT) stake by 8.5% in Q1 2026, selling an estimated $11.7M and leaving 1,322,661 shares worth $115M. The position accounts for 0.12% of the portfolio, ranked #172.

HighTower Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • HighTower Advisors held 1,322,661 shares of Medtronic worth $115M as of Q1 2026.
  • HighTower Advisors sold 122,260 Medtronic shares in Q1 2026, an estimated $11.7M.
  • Medtronic made up 0.12% of HighTower Advisors's portfolio in Q1 2026, its #172 holding.
  • HighTower Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Medtronic position peaked at $139M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.